Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Drugs inhibiting FAAH increase cannabinoid receptor activity in a manner distinct from cannabinoid agonists to treat hypertension, relieve pain or have other therapeutic effect with lessened side effects. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2010 - 20 pages - $125
Mar 2011 - 27 pages - $125
Nov 2010 - 40 pages - $500
Jun 2011 - 34 pages - $125
Jun 2006 - 1068 pages - $2,495
Sep 2011 - 97 pages - $3,500
Nov 2010 - 526 pages - $1,495
Oct 2010 - 53 pages - $1,000
Nov 2011 - 61 pages - $3,800
May 2011 - 25 pages - $125
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us